Galanin activated Gi/o-proteins in human and rat central nervous systems

Neuropeptides

Volumn 48, Issue 5, 2014, Pages 295-304

  Barreda Gomez G ^a   Giralt, M T ^a   Pazos, A ^b   Rodriguez Puertas R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Autoradiography; Basal activity; Gi o proteins activity; Galanin; GPCR; Human; Rat; 35S GTP S

Indexed keywords

GALANIN; GALANIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STRONTIUM;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CENTRAL NERVOUS SYSTEM; FEMALE; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; LEARNING; MALE; MEMORY; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PUTAMEN; RAT; SPINAL CORD; SUBSTANTIA NIGRA; THALAMUS NUCLEUS; ANIMAL; BRAIN; DRUG EFFECTS; METABOLISM; MIDDLE AGED; SPRAGUE DAWLEY RAT;

RATTUS;

ADULT; AGED; ANIMALS; AUTORADIOGRAPHY; BRAIN; FEMALE; GALANIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MALE; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GALANIN; STRONTIUM RADIOISOTOPES;

EID: 84908170408     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2014.06.002     Document Type: Article

References (51)

1. Barreda-Gómez G., Giralt M.T., RodríguezPuertas R. G protein-coupled galanin receptor distribution in the rat central nervous system. Neuropeptides 2005, 39:153-156.
2. Berkowitz D.E., Price D.T., Bello E.A., Page S.O., Schwinn D.A. Localization of messenger RNA for three distinct alpha 2-adrenergic receptor subtypes in human tissues. Evidence for species heterogeneity and implications for human pharmacology. Anesthesiology 1994, 81:1235-1244.
3. Bonnefond C., Palacios J.M., Probst A., Mengod G. Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur. J. Neurosci. 1990, 2:629-637.
4. Borbély E., Scheich B., Helyes Z. Neuropeptides in learning and memory. Neuropeptides 2013, 47:439-450.
5. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends Pharmacol. Sci. 2000, 21:109-116.
6. Burgevin M.C., Loquet I., Quarteronet D., Habert-Ortoli E. Cloning pharmacological characterization and anatomical distribution of rat cDNA encoding for a galanin receptor. J. Mol. Neurosci. 1995, 6:33-41.
7. Burke R.E., Greenbaum D. Effect of postmortem factors on muscarinic receptor subtypes in rat brain. J. Neurochem. 1987, 49:592-596.
8. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimeŕs and Parkinsońs disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 1988, 273:543-557.
9. Duncan G.E., Little K.Y., Koplas P.A., Kirkman J.A., Breese G.R., Stumpf W.E. Beta-adrenergic receptor distribution in human and rat hippocampal formation: marked species differences. Brain Res. 1991, 561:84-92.
10. Duncan G.E., Knapp D.J., Breese G.R., Crews F.T., Little K.Y. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Pharmacol. Biochem. Behav. 1998, 60:439-448.
11. Fastbom J., Pazos A., Probst A., Palacios J.M. Adenosine A1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience 1987, 22:827-839.
12. Fathi Z., Battaglino P.M., Iben L.G., Li H., Baker E., Zhang D., McGovern R., Mahle C.D., Sutherland G.R., Iismaa T.P., Dickinson K.E., Zimanyi I.A. Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor. Brain Res. Mol. Brain Res. 1998, 58:156-169.
13. Floren A., Land T., Langel U. Galanin receptor subtypes and ligand binding. Neuropeptides 2000, 34:331-337.
14. González-Maeso J., Torre I., Rodríguez-Puertas R., García-Sevilla J.A., Guimón J., Meana J.J. Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology 2002, 26:468-478.
15. Gustafson E.L., Smith K.E., Durkin M.M., Gerald C., Branchek T.A. Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 1996, 7:953-957.
16. Hedlund P.B., Yanaihara N., Fuxe K. Evidence for specific N-terminal galanin fragment binding sites in the rat brain. Eur. J. Pharmacol. 1992, 224:203-205.
17. Holmes A., Picciotto M.R. Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction?. CNS Neurol. Disord. Drug Targets 2006, 5:225-232.
18. Jacobowitz D.M., Kresse A., Skofitsch G. Galanin in the brain: chemoarchitectonics and brain cartography - a historical review. Peptides 2004, 25:433-454.
19. Jockers R., Linder M.E., Hohenegger M., Nanoff C., Bertin B., Strosberg A.D., Marullo S., Freissmuth M. Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. J. Biol. Chem. 1994, 269:32077-32084.
20. Kohler C., Chan-Palay V. Cholecystokinin-octapeptide (CCK-8) receptors in the hippocampal region: a comparative in vitro autoradiographic study in the rat, monkey and the post mortem human brain. Neurosci. Lett. 1988, 90:51-56.
21. Kohler C., Chan-Palay V. Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography. Neurosci. Lett. 1990, 120:179-182.
22. Kohler C., Ericson H., Hogberg T., Halldin C., Chan-Palay V. Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298. Neurosci. Lett. 1991, 125:12-14.
23. Kordower J.H., Mufson E.J. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys. J. Comp. Neurol. 1990, 294:281-292.
24. Kordower J.H., Le H.K., Mufson E.J. Galanin immunoreactivity in the primate central nervous system. J. Comp. Neurol. 1992, 319:479-500.
25. Kuteeva E., Wardi T., Lundström L., Sollenberg U., Langel U., Hökfelt T., Ogren S.O. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 2008, 33:2573-2585.
26. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115:177-207.
27. Little K.Y., Duncan G.E., Breese G.R., Stumpf W.E. Beta-adrenergic receptor binding in human and rat hypothalamus. Biol. Psychiatry 1992, 32:512-522.
28. Liu P., Bilkey D.K. Parallel involvement of perirhinal and lateral entorhinal cortex in the polysynaptic activation of hippocampus by olfactory inputs. Hippocampus 1997, 7:296-306.
29. Mazarati A., Lu X., Kilk K., Langel U., Wasterlain C., Bartfai T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur. J. Neurosci. 2004, 19:3235-3244.
30. McMillan P.J., Peskind E., Raskind M.A., Leverenz J.B. Increased galanin receptor occupancy in Alzheimer's disease. Neurobiol. Aging 2004, 25:1309-1314.
31. Melander T., Staines W.A., Hokfelt T., Rokaeus A., Eckenstein F., Salvaterra P.M., Wainer B.H. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res. 1985, 360:130-138.
32. Melander T., Hokfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A., Goldstein M. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 1986, 6:3640-3654.
33. Melander T., Hökfelt T., Rökaeus A. Distribution of galanin-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 1986, 248:475-517.
34. Melander T., Köhler C., Nilsson S., Hökfelt T., Brodin E., Theodorsson E., Bartfai T. Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Chem. Neuroanat. 1988, 1:213-233.
35. Mennicken F., Hoffert C., Pelletier M., Ahmad S., O'Donnell D. Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J. Chem. Neuroanat. 2002, 24:257-268.
36. Miggin S.M., Kinsella B.T. Investigation of the mechanisms of G protein: effector coupling by the human and mouse prostacyclin receptors. Identification of critical species-dependent differences. J. Biol. Chem. 2002, 277:27053-27064.
37. Mufson E.J., Deecher D.C., Basile M., Izenwasse S., Mash D.C. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 2000, 39:1404-1412.
38. O'Donnell D., Ahmad S., Wahlestedt C., Walker P. Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comp. Neurol. 1999, 409:469-481.
39. Palacios J.M., Hoyer D., Cortes R. Alpha 1-adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates. Brain Res. 1987, 419:65-75.
40. Perez S., Basile M., Mash D.C., Mufson E.J. Galanin receptor over-expression within the amygdala in early Alzheimeŕs disease: an in vitro autoradiographic analysis. J. Chem. Neuroanat. 2002, 24:109-116.
41. Reubi J.C., Palacios J.M., Maurer R. Specific luteinizing-hormone-releasing hormone receptor binding sites in hippocampus and pituitary: an autoradiographical study. Neuroscience 1987, 21:847-856.
42. Rodríguez-Puertas R., Pascual J., Pazos A. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissue. Brain Res. 1996, 728:65-71.
43. Rodríguez-Puertas R., Nilsson S., Pascual J., Pazos A., Hökfelt T. 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus. J. Neurochem. 1997, 68:1106-1113.
44. Skofitsch G., Sills M.A., Jacobowitz D.M. Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 1986, 7:1029-1042.
45. Smith K.E., Forray C., Walker M.W., Jones K.A., Tamm J.A., Bard J., Branchek T.A., Linemeyer D.L., Gerald C. Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositoside turnover. J. Biol. Chem. 1997, 272:24612-24616.
46. Waite P.M.E. Trigeminal sensory system. The Rat Nervous System 2004, 817-851. Elsevier Academic Press, San Diego, USA. G. Paxinos (Ed.).
47. Waters S.M., Krause J.E. Distribution of galanin 1, 2 and 3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 2000, 95:265-271.
48. Wang S., Hashemi T., He C., Strader C., Bayne M. Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol. Pharmacol. 1997, 52:337-343.
49. Wang S., Hashemi T., Fried S., Clemmons A.L., Hawes B.E. Differential intracellular signalling of GalR1 and GalR2 galanin receptor subtypes. Biochemistry 1998, 37:6711-6717.
50. Webling K.E.B., Runesson J., Bartfai T., Langel U. Galanin receptors and ligands. Front. Endocrinol. 2012, 3:1-14.
51. Whitehouse P.J., Lynch D., Kuhar M.J. Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. J. Neurochem. 1984, 43:553-559.